Patient Follow-up Sample Clauses

Patient Follow-up. The Group Companies shall, and the Key Founder shall procure the Group Companies to, take all necessary and desirable actions to ensure that as of the date of the Closing and at any time thereafter, at least 80% of the patients followed-up shall have given their informed consent to the Group Companies for further and recurrent commercial use of the personal data collected from such patients, in each case, in accordance with applicable PRC Laws (either by executed consent form or verbal confirmation on a recorded call between the Group Companies’ representatives and such patients). For the purpose of this Section 7.20, “patients followed-up” shall mean patients who have received at least one successful follow-up interviews by representatives of the Group Companies since the date hereof.

Patient Follow-up. This is a noninterventional study. Standard of care at many institutions include the following post-procedure visit intervals: 24-48 hours, at hospital discharge, 7 days, 30 days, and 90 days. Then every 3 months for the first 2 years and then every 6 months until death or 5 years follow up. All follow up—up to 5 years or until death of patient—must be entered. In order to ensure data accuracy, for the first 5 patients entered, the data sheets and their supporting documentation (de-identified labs, treatment dictation, etc.) be sent to the sponsor to verify that data entry is correct and complete (e.g., lesion dimensions, measures of response or progression, etc.).